CHEERS to Patient Engagement

It's Time for Patients to Drive Healthcare ResearchWhen the new CHEERS report was released, we were pleased to see the updated standards regarding patient and stakeholder engagement. These standards reflect a growing recognition that patient and stakeholder engagement need to be incorporated into economic evaluations and healthcare research from the conceptualization stage rather than as [...]

2022-03-16T13:06:42-04:00March 14th, 2022|Blog, CHEERS Blog|

CHEERS to IVI’s Commitment to Transparency

When the updated CHEERS report((Husereau D, Drummond M, Augustovski F, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force. Value In Health. 2022;25(1):10-31.)) encouraged the use of health economic analysis plans (HEAP), we saw this as an opportunity [...]

2022-03-16T13:07:03-04:00March 7th, 2022|Blog, CHEERS Blog|

PRESS RELEASE: IVI Publishes Depression Economic Model Scope

Alexandria, VA — April 12, 2021 — The Innovation and Value Initiative (IVI) — a nonprofit organization dedicated to advancing the science, practice, and use of value assessment in healthcare — today published the initial scope of its Open-Source Value Project Major Depressive Disorder (MDD) economic model. The scope document will be open for public [...]

2021-04-12T11:31:06-04:00April 12th, 2021|Press, Research|

IVI MEMBER SPOTLIGHT: Dr. Wayne Burton

For our first Member Spotlight, we chatted with Dr. Wayne Burton about what he sees as the future of value assessment. Dr. Burton has been with IVI almost since its inception. This interview is an adaptation of a conversation we had with Dr. Burton this fall.     Tell us a little about yourself and [...]

2021-10-26T13:37:28-04:00September 29th, 2020|Blog, Member Spotlight|

Tackling Hard Questions in Value

Author: Jennifer Bright, MPA, Executive Director, IVI For decades, we've known that untreated or poorly treated Major Depressive Disorder (MDD) is an enormous burden on individual patients, our health care system, and our society. Despite having this knowledge, there is much work to do in order to support and optimize cost-effective care for patients suffering [...]

2020-12-29T17:01:00-05:00September 9th, 2020|Blog|

PRESS RELEASE: IVI’s Next Value Assessment Model to Address Major Depressive Disorder Interventions

First of Its Kind Depression Model to be Informed by Input from Diverse Advisory Group September 9, 2020 — Alexandria, VA — The Innovation and Value Initiative (IVI) — a non-profit organization dedicated to advancing the science, practice, and use of value assessment in healthcare — today announced a multi-year initiative to build and test [...]

2021-03-23T18:45:01-04:00September 9th, 2020|News, Press|

PRESS RELEASE: IVI’s Updated RA Model Examines New Treatment Options, Treatment Effects and Cost Estimates

IVI has just released the latest update to the organization's Rheumatoid Arthritis (RA) Value Assessment Model. The updated model now incorporates additional treatment options (triple therapy, Janus Kinase (JAK) inhibitors, sarilumab, and biosimilars), updated treatment effect estimates based on additional randomized controlled trial (RCT) evidence, and updated cost estimates. The model is also designed to [...]

2021-03-23T18:51:39-04:00January 7th, 2020|News, Press|

PRESS RELEASE: IVI Research Brief Discusses Limitations of ICER’s Analysis for JAK Inhibitors

As part of its Value Blueprints series, IVI’s latest research brief grapples with a question prompted by ICER’s recent assessment of RA therapies: Do conventional value assessments address the questions most relevant to real-world decisions about treatment pathways for chronic diseases? In the brief, the authors discuss how the failure of ICER’s analysis to evaluate [...]

2021-03-23T18:52:28-04:00December 10th, 2019|News, Press|

IVI Showcases OSVP at HealthEconomics.com’s “Big Ideas Accelerating Change” Challenge

As one of the nine finalists in HealthEconomics.com's inaugural challenge competition to accelerate change in health economics and outcomes research, IVI's Mark Linthicum offered a compelling case for how IVI's Open-Source Value Platform (OSVP) is catalyzing innovation to shake up value assessment. Mark's presentation, "Using Open-Source Models to Improve Value Assessment in the U.S.", outlined [...]

2019-12-05T15:26:31-05:00December 5th, 2019|News|
Go to Top